MP26-11 TEN-YEAR ONCOLOGIC OUTCOMES FOLLOWING ROBOT ASSISTED RADICAL CYSTECTOMY: RESULTS FROM THE INTERNATIONAL ROBOTIC CYSTECTOMY CONSORTIUM

INTRODUCTION AND OBJECTIVES:Radical cystectomy is the gold standard for muscle invasive bladder cancer. Robot-assisted surgery has been accepted as a suitable alternative. Critics of robot-assisted radical cystectomy (RARC) have shown consensus regarding long term oncologic outcomes. Multi-institutional, ten-year oncologic outcomes for RARC have not been previously reported.METHODS:A retrospective review of the prospectively maintained International Robotic Cystectomy Consortium database was performed. At present 7 institutions of 26 in patients who had RARC over 10 years. 240 patients were reviewed for demographics and perioperative outcomes. Kaplan Meier curves were used to model disease specific survival (DSS), recurrence free survival (RFS), and overall survival (OS) (Fig1a, f). Multivariate Cox regressions models were used to identify predictors.RESULTS:Mean age was 67±11 (range 28-90), BMI was 28±5, and the mean follow up was 47±45 months. 40% patients had a high ASA score (≥3). 6% patients received...